CDHA CAAR

Note: Check with your organization’s library for availability. “Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease,” by Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot, Analiese R. Fernandes, Tarun V. Kamath, Mark B. De Los Santos, Naomi Klickstein, Diana L. Corjuc, Bianca T. Corjuc, Patrick M. Dooley, Arthur Viode, Derek H. Oakley, Benjamin D. Moore, Kristina Mullin, Dinorah Jean-Gilles, Ryan Clark, Kevin Atchison, Renee Moore, Lori B. Chibnik, Rudolph E. Tanzi, Matthew P. Frosch, Alberto Serrano-Pozo, Fiona Elwood, Judith A. Steen, Matthew E. Kennedy & Bradley T. Hyman (Vol. 19, No. 8, August 2020, p. 1256–1263).

www.nature.com/articles/s41591-020-0938-9